Systemic or biologic treatment in psoriasis patients does not increase the risk of a severe form of COVID‐19

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the European Academy of Dermatology and Venereology 2020-11, Vol.34 (11), p.e676-e679
Hauptverfasser:	Fougerousse, A.‐C., Perrussel, M., Bécherel, P.‐A., Begon, E., Pallure, V., Zaraa, I., Chaby, G., Parier, J., Kemula, M., Mery‐Bossard, L., Poreaux, C., Taieb, C., Maccari, F., Reguiai, Z.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Biological Products - therapeutic use Comorbidity COVID-19 - complications COVID-19 Testing Covid‐19 Special Forum Cross-Sectional Studies Dermatologic Agents - therapeutic use Female Humans Letter to the Editor Male Middle Aged Psoriasis - therapy SARS-CoV-2 Telemedicine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!